Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1007/s12035-018-1209-3
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2018
- Creator
-
Schemmert, Sarah
Schartmann, Elena
Zafiu, Christian
Kass, Bettina
Hartwig, Sonja
Lehr, Stefan
Bannach, Oliver
Langen, Karl-Josef
Shah, N. Jon
Kutzsche, Janine
Willuweit, Antje
Willbold, Dieter
- DOI
-
10.18154/RWTH-CONV-238080
- URN
-
urn:nbn:de:101:1-2022020102290464061476
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schemmert, Sarah
- Schartmann, Elena
- Zafiu, Christian
- Kass, Bettina
- Hartwig, Sonja
- Lehr, Stefan
- Bannach, Oliver
- Langen, Karl-Josef
- Shah, N. Jon
- Kutzsche, Janine
- Willuweit, Antje
- Willbold, Dieter
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2018
Other Objects (12)
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Modulation of Alzheimer's pathology in transgenic mouse models
Structural characterisation of autophagy-related protein LC3C
Strukturelle Charakterisierung des Autophagie Assoziierten Proteins ATG101
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Modulation of Alzheimer's pathology in transgenic mouse models
Structural characterisation of autophagy-related protein LC3C
Strukturelle Charakterisierung des Autophagie Assoziierten Proteins ATG101
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Modulation of Alzheimer's pathology in transgenic mouse models
Structural characterisation of autophagy-related protein LC3C